The New Zealand Superannuation Fund is understood to be in the running to buy Healthscope’s New Zealand pathology assets.
As reported in January, Australian private hospital group Healthscope was considering offloading its lab testing business in New Zealand through a sale or initial public
Want to read more? It's easy.
Choose your best value subscription option
Student
Exclusive FREE offer for uni students studying at a New Zealand university (valued at $499).
